Amgen to release Epogen data in face of House panel hearing

06/25/2007 | Forbes

Amgen planned to release data about the dosages of its Epogen anemia drug before today's hearing by a House panel looking into Medicare payments. Critics on the House Ways and Means Subcommittee on Health assert the program's payment system gives doctors an incentive to overprescribe the drug, but Amgen said its data shows physicians have scaled back prescriptions in recent months.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC